Login / Signup
Letter: nutritional benefits of rifaximin in cirrhotic patients.
Patrick Borentain
K Rouabah
G Allard
E Ressiot
R Gerolami
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
irritable bowel syndrome